Ketchikan General Hospital

Details Contact

Name :

Ketchikan General Hospital

Address  :

3100 Tongass Avenue

Town  :

Ketchikan

State  :

Alaska

Country  :

USA

Post Code:

99901

Phone  :

907 225 5171

Web URL  :

Featured Hospitals Listing
Robert Wood Johnson Univ Hosp
One Robert Wood Johnson Place New Brunswick New Jersey (USA)
Phone : 732 828 3000
Email : Not Available
Website URL : Available

Description

Ketchikan General Hospital
Ketchikan General Hospital is a critical access and longterm care facility providing a variety of services including comprehensive trauma inpatient 25 beds outpatient and home health services and a longterm care facility 29 beds

Located on an island 680 air miles from Seattle Washington Ketchikan General Hospital is more selfreliant than most small rural hospitals found in the quotlower 48quot Among the services available at Ketchikan General are Diagnostic Imaging including CT MRI Nuclear Medicine and digital mammography an Intensive Care Unit home health physical and occupational therapy an accredited cancer care program uptodate technology and medical equipment an emergency physician and staff on site 24 hours a day a phase II cardiac rehabilitation program and diabetes education

The medical community is complemented by several EMT services and mediflight service from the outer islands to Ketchikan Ketchikan contracts with medivac companies to provide emergency airlifts to Seattle area hospitals for major traumas
Karmanos Cancer Center receives HealthGrades 2012 Outstanding Patient Experience Award

HealthGrades analyzed patient satisfaction data for 3837 hospitals in the country using Hospital Consumer Assessment of Healthcare Providers and Systems HCAHPS hospital survey data obtained from the Centers for Medicare and Medicaid Services CMS The information was compiled from surveys given to a random sample of patients who were discharged from ... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More